FolioLanternBeta
AXSMAxsome Therapeutics, Inc.

Mark Coleman

Director at Axsome Therapeutics, Inc., as of Jun 10, 2026Sold $8.2M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
434K
shares held after the latest filing, Axsome Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
43K
shares sold, past 12 months
5
days with sales
$4.0M
largest single day, Feb 26, 2026
1
company filed for

Share of stake sold at Axsome Therapeutics, Inc. is not shown: the holdings on record are not confirmed. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFeb 2026: $4.0M under a disclosed plan$4.0MFebMarAprMay 2026: $1.4M under a disclosed planMayJun 2026: $2.8M under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Axsome Therapeutics, Inc. (AXSM)DirectorNov 19, 2015Jun 10, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.